Built on filings, not opinions

Stock Research Tools
That Read the Filings.

Ten years of financials, the 10-K, the earnings calls and a check on management — for around 4,400 US companies, all analysed the same way.

Start free — no signup

No email · no card · $29/month or $250/year for the full list

Screener — Undervalued
Undervalued StocksTrading below intrinsic value
S&P 500The 500 large-caps
Dow 30The blue-chip Dow
Spin-off calendarUpcoming US spinoffs
WishlistYour saved stocks
Deeply undervalued (1)

Our deepest-value opportunities

28 Jul 2025

DD

0.91%

DuPont de Nemours, Inc.

$94.23

Buy range

$113–$170

Intrinsic value range$339–$374
150-day avg$91.07

Basic Materials

+49.4%one year

28 Jul 2026one year later

DD

0.21%

DuPont de Nemours, Inc.

$140.77

150-day avg

$138.72

Value range estimated 28 Jul 2025$339–$374

Basic Materials

Adjusted for the Qnity spin-off and the 1-for-3 reverse split

one name at this depth

Left card, 28 July 2025. Right card, 28 July 2026. The screener’s own output a year back, next to where each name actually closed — price only, dividends excluded, which understates every figure rather than flattering it. The right-hand card carries a price, not a fresh valuation: the value range on it is the one estimated in 2025, shown so you can see the price against it. PARA has no pair because Paramount Global was folded into Paramount Skydance during 2025 and no longer trades under that ticker. DD is on a basis adjusted for its Qnity Electronics spin-off and 1-for-3 reverse split, so both of its figures are the same unit. Nothing was chosen with hindsight: these are the screener’s own rows, KMX included, which finished the year down. Past performance is not a prediction, and none of this is advice.

The analysis, not the quote.

01

Research, not a price checker

If you want today's quote there are a dozen free sites and you should use one. Hety is for the next question: what the business is actually worth on its filed numbers, and whether the price makes sense against that.

02

One method, every company

Around 4,400 US companies across the NYSE, Nasdaq, S&P 500 and Dow 30, each put through the same analysis. That is what makes two names comparable instead of two write-ups you have to reconcile yourself.

03

The reading, done

Ten years of statements, the 10-K, the earnings calls. The work a thorough analyst would do and almost nobody has the hours for — summarised with the source kept in view, not replaced by a score.

Stock analysis tool

Ten years of financials, read for you

Hety turns a company's 10-K, its earnings calls and a decade of statements into a clear picture: what it earns, what it owes, how stable that has been, and what the numbers imply the business is worth. The source stays in view throughout, so the analysis is something you can check rather than something you have to believe.

  • An intrinsic value range built from ten years of filed results
  • Graham's classic tests, passed or failed, with the numbers shown
  • 10-K and earnings-call summaries with the passages they came from
  • DCF and compounding tools when you want to run your own assumptions
Price against estimated value
UndervaluedMarket ValueOvervalued
  1. 01Adequate sizeMarket cap above $2B
  2. 02Low debt to equityDebt / equity under 1.1
  3. 03Earnings stabilityProfitable, with no collapse in earnings
  4. 04Dividend historyPays a dividend
  5. 05Earnings growthAbove 3%, on the 10-yr average where it exists
  6. 06Moderate P/EPrice / earnings under 15
  7. 07Moderate P/BPrice / book under 1.5
Criteria passed / 7

Each row is scored against the company's own reported figure and explained in a sentence, so a fail tells you how badly and a pass tells you by how much.

Investment research tools

Check the story against the filings

Executives are coached to sound confident and say little. The gap between what they say and what the company files is where the real information is, and almost nobody reads both. Hety reads both — recent interviews, earnings calls and the filings — and shows you the passages where the two stop matching.

  • A read on the CEO from recent interviews and earnings calls
  • Public statements cross-referenced against the filings
  • The passages where the two diverge, shown side by side
  • Flags raised from the documents, with the document cited

Integrity score · 0–100

Management integrity

Synthesized from recent recordings of the chief executive and read against what the company has filed, then aggregated into one figure alongside quotes.

Passages worth a second look

“…the claim made on the call…”

sits against

“…the position stated in the filing…”

“…an answer that doesn’t settle the question asked…”

flagged for review

10-K vs. earnings call4 topics · 3 calls
  • Gross margin

    Watch

    10-K

    Margin declined year over year on higher input and freight costs.

    Earnings call

    Described as broadly stable, with the decline framed as timing.

    Reality: The direction agrees. The framing does not. Check the quarterly trend yourself.

  • Customer concentration

    Contradiction

    10-K

    Disclosed as a risk factor: a small number of customers is a large share of revenue.

    Earnings call

    Described as a broad, diversified base with no material dependency.

    Reality: The filing discloses a dependency the call denies. This is the gap worth reading twice.

  • Guidance

    Aligned

    10-K

    No forward guidance; forward-looking statements are qualified in the risk factors.

    Earnings call

    Full-year range reaffirmed, with the second half doing the heavier lifting.

    Reality: Consistent, but the shape of the year is a spoken claim the filing does not support.

  • Capital allocation

    Aligned

    10-K

    Buyback authorization and dividend policy stated, with leverage covenants disclosed.

    Earnings call

    Same priorities, same order, no new commitments.

    Reality: Nothing said on the call that the filing does not already carry.

Alerts

Told when something actually changes

A business is interesting because of its fundamentals, not because the price moved this morning. Hety watches the fundamentals and uses live prices to tell you when a company you are following crosses into the range you cared about — and stays quiet the rest of the time.

  • Told when a stock you're watching crosses into buying range
  • Reaches you by email, in the browser, or in the app
  • Silent when nothing has changed — no daily noise
  • A wishlist that follows you across devices

Changes since yesterday's close

After US close
  • •••UndervaluedDeeply undervalued
  • •••Not on the listUndervalued
  • •••Slightly undervaluedNot on the list

Tier transitions, in the shape you receive them. Tickers are withheld here — this is a marketing page, not a live list.

Three simple steps

01

See what's priced well today

Open the screener and see which businesses trade below what they're worth — or look up any stock directly.

02

Update your knowledge

Intrinsic value, Graham's tests, ten years of numbers, the investment case, and a check on management — all in one place.

03

Make clear decisions

Save it, and get told when the price or value changes so that you can act on an opportunity

One plan. Dive into the research that matters.

No tiers engineered to put the useful parts behind a second paywall.

Hety Pro

$29

per month

$250 / year

Save $98 — about 28% off, two months free

Start free — no signup

Free to start · no signup · no card · $29/month for the full list

  • Every S&P 500 and Dow 30 company, valued
  • The Undervalued screener and all three bands
  • Graham analysis and intrinsic value on every stock
  • Management-integrity checks and filing cross-reference
  • AI thesis and 10-K summaries
  • The weekly spin-off calendar
  • Ten years of financials, DCF and compounding tools
  • Alerts by email, browser and in-app
  • A wishlist that follows you across devices

Straight answers

Is this a stock screener or a research tool?+

Both, and they are the same thing here. The screener shows which companies trade below the value their filings imply; opening any one of them gives you the full analysis — ten years of figures, Graham's tests, the 10-K summary and the management check. You can also skip the screener and look a company up directly.

Can I just check a stock price here?+

You can see live prices, but that is not what Hety is for and you would be better served by a free quote site. This is for the analysis that comes after the price: what the business earns, what it owes, what ten years of filings imply it is worth, and whether the people running it are being straight.

Where do the numbers come from?+

Company filings from SEC EDGAR, audited financial statements, earnings-call transcripts and live market prices. Every valuation is built from ten years of a company's own reported figures — never a forecast, never a single flattering year.

Does the AI invent things when it doesn't know?+

It is built specifically not to, though AI can make mistakes. If a filing is missing or a transcript cannot be sourced, Hety shows that the section is unavailable instead of producing a plausible-sounding number. A research tool that guesses can be worse than no tool.

Do I connect my brokerage?+

Never. Hety does research and nothing else. It cannot see your accounts, cannot place trades, and does not ask for broker credentials.

What does it cover?+

The NYSE and the Nasdaq, plus the S&P 500 and the Dow 30 — around 4,400 US companies, every one analysed the same way so they are directly comparable. Upcoming spin-offs are tracked too.

What can I see for free?+

Click Start free and you are in — no signup, no email, no card. You get one company from each undervalued tier, openable in full with every tool on it. Add an email (still free, still no card) and every exchange opens up. The full undervalued list is what the $29 subscription is for.

Monthly or yearly?+

Either. $29 a month, or $250 a year — which works out about 28% cheaper, roughly two months free. Cancel any time in one click from settings; billing runs through Stripe so your card details never touch Hety.

Start with the company you've been wondering about.

Ten years of its filings, read and laid out, in about the time it takes to make coffee.

Start free — no signup

No card required · then $29/month or $250/year · cancel any time

Hety provides research, analysis and educational tools for informational purposes only. Hety is not a registered investment adviser, broker or dealer, and nothing here is personalized investment advice or a recommendation to buy or sell any security. Valuations are estimates produced from historical filed fundamentals; they are not forecasts, and a share price may never reach an estimated range. Investing involves risk, including possible loss of principal. Past performance does not indicate future results. Do your own research and consider speaking to a licensed professional.

Hety is an independent product, not affiliated with or endorsed by any company or index provider referenced on this site.

© 2026 Hety

$29/month

Cancel in one click

Sign Up Today